Challenges For Euro Wholesalers

29 May 1997

In Europe's 15 principal markets, drug wholesalers face increasingcompetition, says OTC Distribution in Europe, an Analysis of Structure, Changes and Trends, a new study from James Dudley International. Demands on levels of service they must offer to retailers are rising.

Actions being taken include: national and international mergers, acquisitions and cooperative groupings; vertical integration policies; and, where ownership of retail pharmacy chains is banned, formation of voluntary trading groups for which services provided include marketing, advice, training and private-label brands. To offer a competitive service, wholesalers must meet increasing capital investment demands, which is leading to consolidation and a decline in their numbers.

In France, the UK and Germany, over 70% of the market is controlled by three wholesalers, while in Belgium the top three have 40%. In Spain, with over 100 wholesalers, the share is 31%. Of Italy's 220 wholesalers, the top three hold 28%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight